Bioclonal Receives the Innovative SME Seal

We have been awarded the Innovative SME Seal, a distinction granted by the Ministry of Science, Innovation and Universities of the Government of Spain, valid until April 14, 2028. This recognition certifies our capacity for innovation and our commitment to scientific research and technological development in the field of biotechnology. It serves as an endorsement […]
BioClonal drives innovative solutions against antimicrobial resistance

Antimicrobial resistance (AMR) remains one of the most pressing global health threats, jeopardizing both modern medicine and the achievement of the Sustainable Development Goals. Every year, millions of lives are affected by infections caused by resistant bacteria, and it is estimated that, without urgent action, AMR could cause up to 10 million deaths annually by […]
Jessika Valero receives de IMPULSA Award for Female Leadership

We are thrilled to announce that our Technical Director, Jessika Valero, has been honored with the prestigious IMPULSA Award for Female Leadership. This recognition celebrates exceptional female talent and leadership, acknowledging the drive, career achievements, and future potential of outstanding women in executive roles. Jessika shared this proud moment with fellow honoree Paloma Yarza, President […]
DESAFÍA BOSTON

BioClonal has been selected to represent Spanish biotechnology at the prestigious Desafía Boston program, organized by Richi Entrepreneurs and ICEX. This program offers participants a unique opportunity to expand their international presence and engage with Boston’s thriving biotech community.On October 1st, the first session took place in Madrid, where Pablo Caño delivered an inspiring workshop […]
A DAY WITH A BIOTECH WOMAN – AseBio

BioClonal actively participated in the second edition of the #UnDíaConUnaMujerBiotech program, an initiative promoted by the Spanish Bioindustry Association (AseBio) aimed at introducing female students to the professional world of biotechnology. This program offers future scientists the opportunity to closely observe how companies in the sector operate, promoting visibility and female talent in this key […]
PEGS BOSTON

BioClonal proudly participated in the PEGS Boston 2024 Summit, held from May 13th to 17th, where our CEO Paula and CSO Jessika represented the company at one of the most prestigious global conferences in antibody research. The event offered a unique platform for BioClonal to connect with industry leaders, exchange insights, and explore the latest […]
IDEA AWARD

BioClonal has been awarded in the XXIX edition of the IDEA Contest, in the IDEA Project category. This is one of the oldest competitions to recognise entrepreneurial and innovative initiatives in our community and one of the oldest in the country. It is organised by the Department of Industry, Competitiveness and Business Development, through the […]
AIS CONGRESS MONTPELLIER

BioClonal participated in the 12th Antibody Industrial Symposium (AIS Congress), the largest monoclonal antibody event in France, which took place on June 20-21, 2024, at the CORUM Conference Center in Montpellier. The event, organized by LabEx MAbImprove and MabDesign, brought together key players in the biotechnology sector to discuss the latest advancements and foster collaboration.Represented […]
PREMIO EMPRENDE XXI – DAY INNOVATION SUMMIT CAIXABANK

Yesterday, the DayOne Innovation Summit in Aragón took place, a key event for innovative entrepreneurship in the region, organized by CaixaBank in collaboration with the Aragón Emprende Foundation. The event was part of the 17th edition of the EmprendeXXI Award, which aims to recognize the most innovative startups in each autonomous community.Among the finalists, BioClonal […]
PEGS EUROPE – Lisboa

Last November, in Lisbon, we attended #PEGSEUROPE , the 15th Annual Protein & Antibody Engineering Summit and one of the most renowned conferences in the field. BioClonal had the opportunity to explain scientific advances with the posters presentations: ➡ A003: Rational Antibody Discovery: Novel Target for Alzheimer Disease Reachable with RedMabs, presented by our Chief Executive Officer Paula Garfella➡ B025: […]